ADAM23 and breast carcinoma: For example, one study demonstrated that the survival of patients with breast cancer presenting CTCs with mesenchymal characteristics and no ADAM23 hypermethylation was similar to that of patients with no detectable CTCs and ADAM23 hypermethylation (59).